Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
David A. Eiznhamer
Observed names:
D Eiznhamer,
D. A. Eiznhamer,
D. Eiznhamer,
David A Eiznhamer,
David Eiznhamer,
Eiznhamer David A.
show all 6
Observed institutions:
Loyola University Medical Center,
Loyola University Chicago,
Loyola Medicine,
Kadmon Corporation (United States)
OpenAlex ID:
A5068366823
Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study
2021
·
Corey Cutler
, Stephanie J. Lee
, et al.
·
Blood
·
366
ROCK2 Inhibition With Belumosudil (KD025) for the Treatment of Chronic Graft-Versus-Host Disease
2021
·
Madan Jagasia
, Aleksandr Lazaryan
, et al.
·
Journal of Clinical Oncology
·
198
Betulinic acid: a promising anticancer candidate.
2004
·
David A Eiznhamer
, Ze-Qi Xu
·
PubMed
·
121
Mucosal reactive oxygen species production in oesophagitis and Barrett's oesophagus.
1995
·
M Olyaee
, S Sontag
, et al.
·
Gut
·
102
PDF
Safety and Pharmacokinetics of Single Doses of (+)-Calanolide A, a Novel, Naturally Occurring Nonnucleoside Reverse Transcriptase Inhibitor, in Healthy, Human Immunodeficiency Virus-Negative Human Subjects
2001
·
Terri Creagh
, Jon L. Ruckle
, et al.
·
Antimicrobial Agents and Chemotherapy
·
94
Glutathione Content of Colonic Mucosa (Evidence for Oxidative Damage in Active Ulcerative Colitis)
1998
·
E. W. Holmes
, S. L. Yong
, et al.
·
Digestive Diseases and Sciences
·
87
Elevated breath ethane levels in active ulcerative colitis: evidence for excessive lipid peroxidation.
1994
·
S Sedghi
, A Keshavarzian
, et al.
·
PubMed
·
61
Safety and Pharmacokinetic Profile of Multiple Escalating Doses of (+)-Calanolide A, a Naturally Occurring Nonnucleoside Reverse Transcriptase Inhibitor, in Healthy HIV-Negative Volunteers
2002
·
Eiznhamer David A.
, Creagh Terri
, et al.
·
HIV Clinical Trials
·
38
PDF
Synthesis and cytotoxicity of 2-cyano-28-hydroxy-lup-1-en-3-ones
2009
·
Ali Koohang
, Nathan D. Majewski
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
29
Cethromycin versus Clarithromycin for Community-Acquired Pneumonia: Comparative Efficacy and Safety Outcomes from Two Double-Blinded, Randomized, Parallel-Group, Multicenter, Multinational Noninferiority Studies
2012
·
Marci L. English
, Christine E. Fredericks
, et al.
·
Antimicrobial Agents and Chemotherapy
·
27
Expression of the INO2 regulatory gene of Saccharomyces cerevisiae is controlled by positive and negative promoter elements and an upstream open reading frame
2001
·
David A. Eiznhamer
, Brian P. Ashburner
, et al.
·
Molecular Microbiology
·
25
Synthesis and cytotoxicity of 28-carboxymethoxy lupane triterpenoids. Preference of 28-O-acylation over 28-O-alkylation of betulin by ethyl bromoacetate
2009
·
Aye Aye Mar
, Ali Koohang
, et al.
·
Chinese Chemical Letters
·
16
Synthesis, proapoptotic screening, and structure–activity relationships of novel aza-lupane triterpenoids
2010
·
Aye Aye Mar
, Erika L. Szotek
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
15
Belumosudil for Chronic Graft-Versus-Host Disease (cGVHD) after 2 or More Prior Lines of Therapy: The Rockstar Study (KD025-213)
2020
·
Corey Cutler
, Stephanie J. Lee
, et al.
·
Blood
·
14
Determination of the maximum tolerated dose (MTD) of the CNS penetrant tyrosine kinase inhibitor (TKI) tesevatinib administered in combination with trastuzumab in HER2+ patients with metastatic breast cancer (BC).
2016
·
Nancy U. Lin
, Rachel A. Freedman
, et al.
·
Journal of Clinical Oncology
·
14
Modulation of neutrophil function by novel colonic factors: possible role in the pathophysiology of ulcerative colitis.
1995
·
N Kazi
, J Z Fields
, et al.
·
PubMed
·
13
Macrolides and Ketolides
2011
·
Ze-Qi Xu
, Michael T. Flavin
, et al.
·
Springer eBooks
·
11
KD025 for Patients with Chronic Graft-Versus-Host Disease (cGVHD) - Long-Term Follow-up of a Phase 2a Study (KD025-208)
2019
·
Madan Jagasia
, Amandeep Salhotra
, et al.
·
Blood
·
10
Effective attenuation of endotoxin-induced acute lung injury by 2,3-diacetyloxybenzoic acid in two independent animal models
2004
·
David A. Eiznhamer
, Michael T. Flavin
, et al.
·
Pulmonary Pharmacology & Therapeutics
·
10
Susceptibility of 170 isolates of the USA300 clone of MRSA to macrolides, clindamycin and the novel ketolide cethromycin
2008
·
V. A. Luna
, Z.-Q. Xu
, et al.
·
Journal of Antimicrobial Chemotherapy
·
9
The effect of a selective 5-lipoxygenase inhibitor, zileuton, on tissue damage in acute colonic inflammation in rats
1996
·
Adil Zarif
, David Eiznhamer
, et al.
·
Inflammation
·
9
KD025-208: A Phase 2a Study of KD025 for Patients with Chronic Graft Versus Host Disease (cGVHD) — Pharmacodynamics and Updated Results
2018
·
Madan Jagasia
, Amandeep Salhotra
, et al.
·
Blood
·
8
Belumosudil for Chronic Graft-Versus-Host Disease (cGVHD) after 2 or More Prior Lines of Therapy: The Rockstar Study (KD025-213)
2021
·
Corey Cutler
, Stephanie J Lee
, et al.
·
Transplantation and Cellular Therapy
·
6
KD025 for Patients with Chronic Graft-Versus-Host Disease (cGVHD) – Long-Term Follow-up of a Phase 2a Study (KD025-208)
2020
·
Daniel J. Weisdorf
, Madan Jagasia
, et al.
·
Transplantation and Cellular Therapy
·
4
KD025-208: A Phase 2a Study of KD025 for Patients with Chronic Graft Versus Host Disease (cGVHD) - Pharmacodynamics (PD) and Updated Results
2019
·
Madan Jagasia
, Amandeep Salhotra
, et al.
·
Transplantation and Cellular Therapy
·
4
PDF
Show more works
View as search
Works count:
36
Citation count:
1,308
H-index:
14
I10-index:
19
Year
Topic
Type
